West Pharmaceutical Services, Inc. (WST) CFO William J. Federici Sells 21,000 Shares

West Pharmaceutical Services, Inc. (NYSE:WST) CFO William J. Federici sold 21,000 shares of the stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $99.01, for a total transaction of $2,079,210.00. Following the completion of the sale, the chief financial officer now owns 190,493 shares of the company’s stock, valued at approximately $18,860,711.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

West Pharmaceutical Services, Inc. (NYSE WST) traded down $0.55 on Tuesday, reaching $99.08. 175,300 shares of the company traded hands, compared to its average volume of 361,198. The company has a market capitalization of $7,397.82, a price-to-earnings ratio of 42.94, a P/E/G ratio of 2.12 and a beta of 1.11. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 2.59. West Pharmaceutical Services, Inc. has a one year low of $77.97 and a one year high of $103.36.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.14. The company had revenue of $398.20 million during the quarter, compared to analyst estimates of $386.02 million. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.53 earnings per share. equities analysts predict that West Pharmaceutical Services, Inc. will post 2.76 EPS for the current year.

Several analysts have recently commented on the stock. Stephens assumed coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 target price for the company. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Wednesday, September 27th. Wells Fargo & Company increased their target price on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Bank of America downgraded shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 target price for the company. in a report on Tuesday, October 17th. Finally, Jefferies Group upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and increased their target price for the company from $96.00 to $115.00 in a report on Friday, September 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. West Pharmaceutical Services presently has an average rating of “Hold” and an average price target of $106.00.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in West Pharmaceutical Services by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,735 shares of the medical instruments supplier’s stock valued at $1,015,000 after buying an additional 34 shares during the period. Teacher Retirement System of Texas boosted its position in West Pharmaceutical Services by 0.7% during the second quarter. Teacher Retirement System of Texas now owns 5,867 shares of the medical instruments supplier’s stock worth $555,000 after purchasing an additional 40 shares during the period. Hillsdale Investment Management Inc. boosted its position in West Pharmaceutical Services by 0.7% during the second quarter. Hillsdale Investment Management Inc. now owns 12,080 shares of the medical instruments supplier’s stock worth $1,142,000 after purchasing an additional 80 shares during the period. Utah Retirement Systems boosted its position in West Pharmaceutical Services by 1.5% during the second quarter. Utah Retirement Systems now owns 13,400 shares of the medical instruments supplier’s stock worth $1,266,000 after purchasing an additional 200 shares during the period. Finally, Commerce Bank boosted its position in West Pharmaceutical Services by 1.4% during the second quarter. Commerce Bank now owns 15,765 shares of the medical instruments supplier’s stock worth $1,490,000 after purchasing an additional 215 shares during the period. Institutional investors own 93.28% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “West Pharmaceutical Services, Inc. (WST) CFO William J. Federici Sells 21,000 Shares” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.thelincolnianonline.com/2017/12/12/west-pharmaceutical-services-inc-wst-cfo-william-j-federici-sells-21000-shares.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply